TRAF3 Gene: Structure, Function, and Clinical Significance

A comprehensive overview of the TRAF3 gene, its protein product, associated diseases, and molecular mechanisms.

Gene Information Card

Symbol TRAF3
Full Name TNF receptor associated factor 3
Gene Type protein coding
Chromosomal Location 14q32.33
NCBI Gene ID 7187 ncbi.nlm.nih.gov/gene/7187
Ensembl ID ENSG00000131323
UniProt ID Q13114
OMIM ID 601896
HGNC ID 12029
Aliases CAP-1, CD40bp, CRAF1, LAP1

Description

The TRAF3 gene encodes TNF receptor-associated factor 3, a key adaptor protein that regulates signaling pathways for various TNF receptor superfamily members and pattern recognition receptors. TRAF3 plays a critical role in innate and adaptive immunity, particularly in type I interferon production, NF-κB activation, and B-cell survival. It also functions as a tumor suppressor in multiple cancers, especially in multiple myeloma and B-cell lymphomas. Mutations and deletions of TRAF3 are frequently observed in human malignancies and can lead to immune dysregulation.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Multiple Myeloma Loss-of-function mutations or deletions of TRAF3 lead to constitutive NF-κB activation, promoting plasma cell survival and proliferation. COSMIC; frequent somatic mutations in multiple myeloma (e.g., ~10-15% of cases).
B-cell Lymphoma Inactivating mutations and deletions of TRAF3 contribute to lymphomagenesis by deregulating NF-κB and B-cell survival pathways. COSMIC; recurrent alterations in various B-cell lymphomas.
Herpes Simplex Encephalitis (HSE) Heterozygous mutations in TRAF3 impair TLR3-mediated type I interferon responses, increasing susceptibility to HSV-1 encephalitis. ClinVar; reported in patients with HSE.
Common Variable Immunodeficiency (CVID) TRAF3 mutations may disrupt B-cell signaling and antibody production, contributing to CVID phenotype. ClinVar; rare variants reported.
Waldenström Macroglobulinemia TRAF3 deletions or mutations are found in a subset of cases, leading to NF-κB activation and tumor growth. COSMIC; somatic alterations observed.

Expression Profile

Tissue Expression
Tissue nTPM level
Lymphoid tissues (spleen, lymph node, tonsil) High (e.g., >50 nTPM) High expression in immune cells.
Bone marrow Moderate (e.g., 20-50 nTPM) Expression in hematopoietic cells.
Liver Low (e.g., <10 nTPM) Low expression.
Brain Low (e.g., <10 nTPM) Low expression.
Cell Line Expression
Cell Line nTPM Notes
Ramos (Burkitt lymphoma) High (e.g., >50 nTPM) B-cell line with high TRAF3 expression.
K562 (chronic myeloid leukemia) Moderate (e.g., 20-50 nTPM) Myeloid cell line.
HeLa (cervical carcinoma) Low (e.g., <10 nTPM) Epithelial cell line.
HepG2 (hepatocellular carcinoma) Low (e.g., <10 nTPM) Liver cell line.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1120C>T (p.Arg374Ter) Nonsense Rare (somatic) Truncated protein, loss of function.
c.1129A>G (p.Lys377Glu) Missense Rare (somatic) Impaired TRAF3 function.
Deletion of 14q32.33 Copy number loss Frequent in multiple myeloma Loss of heterozygosity, reduced TRAF3 expression.
c.1180G>A (p.Glu394Lys) Missense Rare (germline) Impaired TLR3 signaling, associated with HSE.
Mutation functional classification

Loss of Function (LOF)

Most TRAF3 mutations in cancer are loss-of-function, leading to constitutive NF-κB activation and enhanced cell survival.

Gain of Function (GOF)

Gain-of-function mutations are rare; some variants may enhance TRAF3 activity but are not well characterized.

Dominant Negative (DN)

Certain missense mutations may act in a dominant-negative manner, interfering with wild-type TRAF3 function in signaling complexes.

Gene Ontology (GO)

• protein binding • signal transducer activity
• ubiquitin protein ligase binding • zinc ion binding
• cytoplasm • cytosol
• nucleus • TNF receptor-associated factor complex
• regulation of NF-kappaB signaling • innate immune response
• type I interferon signaling pathway • B cell homeostasis

Pathways

TNF receptor signaling pathway
TLR signaling pathway
RIG-I-like receptor signaling pathway
NF-kappaB signaling pathway
Type I interferon production
B cell receptor signaling

Protein Summary

TRAF3 is a 568-amino acid protein containing a RING finger domain, multiple zinc finger motifs, and a TRAF domain. It functions as a scaffold for signaling complexes, mediating ubiquitination events that regulate NF-κB and IRF3/7 activation. TRAF3 is essential for type I interferon production in response to viral infection and for B-cell survival and maturation. In cancer, loss of TRAF3 leads to aberrant NF-κB signaling, promoting tumorigenesis.

Related Products

Product name Cat.No. Species Gene ID
TRAF3 Knockout HEK293 Cell Line EDJ-KQ602 Human 7187 Details Get a Quote
TRAF3IP2 Knockout HEK293 Cell Line EDJ-KQ7153 Human 10758 Details Get a Quote
TRAF3IP3 Knockout HEK293 Cell Line EDJ-KQ8779 Human 80342 Details Get a Quote
TRAF3 Knockout A-549 Cell Line EDJ-KQ19046 Human 7187 Details Get a Quote
TRAF3 Knockout HCT 116 Cell Line EDJ-KQ19047 Human 7187 Details Get a Quote
TRAF3 Knockout HeLa Cell Line EDJ-KQ19048 Human 7187 Details Get a Quote
TRAF3IP2 Knockout A-549 Cell Line EDJ-KQ32053 Human 10758 Details Get a Quote
TRAF3IP2 Knockout HCT 116 Cell Line EDJ-KQ32054 Human 10758 Details Get a Quote
TRAF3IP2 Knockout HeLa Cell Line EDJ-KQ30676 Human 10758 Details Get a Quote
TRAF3IP3 Knockout HeLa Cell Line EDJ-KQ57331 Human 80342 Details Get a Quote
TRAF3IP3 Knockout A-549 Cell Line EDJ-KQ65837 Human 80342 Details Get a Quote
TRAF3IP3 Knockout HCT 116 Cell Line EDJ-KQ74262 Human 80342 Details Get a Quote
Displaying Records 1 To 12 Of 12 Records
Contact Us
*
*
*
*
How did you hear about us: